Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Measured vs Potere Health MD

Measured costs $1 less a month, and both sell semaglutide and tirzepatide.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed (not clinically reviewed). Not medical advice · How we verify contentLast reviewed
Measured logo

Measured

7.9
★★★★☆4/5

Best for: starting below a standard dose, with microdose tiers

Visit Measured →
VS
Potere Health MD logo

Potere Health MD

5.4
★★★☆☆2.7/5

Best for: a published list of the one state it serves, when most sellers publish none

Visit Potere Health MD →

If you are choosing between Measured and Potere Health MD, the first difference is cost: Measured is $1 a month cheaper at the entry price. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Measured leads our six-part score, 7.9 to 5.4. One of the two has an FDA warning letter on record, covered below.

Measured vs Potere Health MD price

Measured is the cheaper way in: $79 a month against $80 a month at Potere Health MD. That is $1 less each month (1% lower), or about $12 over a year of treatment.

Drug by drug: Semaglutide is cheaper at Measured ($79 a month vs $80 a month); tirzepatide is cheaper at Potere Health MD ($135 a month vs $229 a month).

Medications and formats

Both sell semaglutide and tirzepatide.

On format, Measured prices compounded injections and brand-name pens, while Potere Health MD prices compounded injections.

If you want the FDA-approved brand rather than a compounded version, Measured is the only one of the two with a brand-name price.

Where each one treats patients

Measured does not publish where it ships, and Potere Health MD lists 1 state.

Pricing

Measured

MicrodoseCompounded
$79/mo
semaglutide

Weekly lower-dose semaglutide or tirzepatide (compounded).

StandardCompounded
$119/mo
semaglutide

Compounded semaglutide.

StandardCompounded
$229/mo
tirzepatide

Compounded tirzepatide.

BrandBrand-name
$299/mo
semaglutide

Wegovy; cash-pay estimate, varies with coverage.

BrandBrand-name
$349/mo
tirzepatide

Zepbound; cash-pay estimate, varies with coverage.

Potere Health MD

Starting planCompounded
$80/mo
semaglutide
Starting planCompounded
$135/mo
tirzepatide

What each price covers

Both prices cover the clinician visit and the medication itself.

Measured's price also covers coaching, which Potere Health MD does not claim.

Measured is silent on shipping and lab work.

Potere Health MD is silent on shipping, lab work and coaching.

Measured

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

Not stated

Lab work

Not stated

Coaching

In the price

Potere Health MD

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

Not stated

Lab work

Not stated

Coaching

Not stated

Where each one scores higher

Overall, Measured scores 7.9 and Potere Health MD 5.4 out of 10.

Measured is stronger on value (10.0 vs 3.0), user experience (8.0 vs 3.0), accessibility (5.0 vs 2.2) and support (7.0 vs 5.5).

Potere Health MD is stronger on trust & safety (6.0 vs 3.5).

Effectiveness is within half a point.

How we score

Measured

7.9/10

Overall

Potere Health MD

5.4/10

Value25%

10.0A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
3.0

Trust & Safety15%

3.5A
vs
B
6.0

Accessibility10%

5.0A
vs
B
2.2

Support10%

7.0A
vs
B
5.5

FDA warning letters

The FDA sent Measured a warning letter dated February 20, 2026 (letter 721454), and it is still open.

Potere Health MD has no FDA warning letter on record with us.

Features & Coverage

FeatureMeasuredPotere Health MD
Starting Price✓$79/mo$80/mo
Features6 features✓8 features
States AvailableNot disclosed1
Compounded✓ Yes✓ Yes
Brand Name✓ Yes—
FSA/HSA Accepted——
FDA Warning Letters1 letter✓None

About Measured

A membership of $49/mo is charged on its own, separate from the drug. On top of it sit compounded GLP-1, semaglutide and tirzepatide, opening at $79/mo for the microdose, plus Wegovy and Zepbound under their brand names. The proposition is metabolic health rather than a prescription alone, with 1:1 nutrition support and care from board-certified providers attached.

Read our full Measured review →

About Potere Health MD

Potere Health MD runs no subscription, and its entry price sits around $80 to $135/month. Dr. Joshua Silva, MD leads the Utah clinic, writing semaglutide and tirzepatide in FDA-approved and compounded forms alike, seen either by telehealth or in person at Cedar City, Salt Lake City and St. George. Appointments come same or next day, and you either collect or take delivery anywhere in the state. The clinic points to third-party Certificate of Analysis checks and a LegitScript-certified pharmacy. Compounded drugs hold no FDA approval.

Read our full Potere Health MD review →

Pros & Cons

Measured

What we like

  • Semaglutide costs $79 a month, 57% below the $185 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $229 a month, close to the $250 median for compounded tirzepatide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication, clinician visits and coaching

Watch-outs

  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • The FDA has issued Measured a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Potere Health MD

What we like

  • The monthly price includes the medication and clinician visits
  • We found no FDA warning letters issued to Potere Health MD

Watch-outs

  • You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
  • Serves only 1 states, so check that yours is one of them
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Measured

Measured wins this one, 7.9 to 5.4, above all for starting below a standard dose, with microdose tiers. It also costs $1 less each month than Potere Health MD. Potere Health MD fits better if a published list of the one state it serves, when most sellers publish none is your priority.

Choose Measured if…

You want starting below a standard dose, with microdose tiers and an opening price near $79 a month.

Choose Potere Health MD if…

You want a published list of the one state it serves, when most sellers publish none and an opening price near $80 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

6.4

ShedRx

Oral orforglipron alongside the injectables

9.0

bmiMD

Starting below a standard dose, with microdose tiers

6.7

RxSpan MD

Knowing which pharmacy fills the vial: it names Belmar Pharmacy

Measured vs Potere Health MD: FAQ

Measured. It starts at $79 a month; Potere Health MD starts at $80 a month, $1 more per month.
Yes, both sell semaglutide and tirzepatide.
Measured does not publish where it ships; Potere Health MD lists 1 state. Confirm your state before paying.
Both include the clinician visit and the medication itself. Only Measured includes coaching.
Measured has an open FDA warning letter from February 20, 2026. Potere Health MD has none.
No. Neither Measured nor Potere Health MD pays us anything.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.